Press reviews
By Ana Espino | Published on october 15, 2025 | 2 min read
#Oncology #MetastaticBreastCancer #MBC #PlantMetabolites
Metastatic breast cancer (MBC) represents the most advanced stage of the disease and remains incurable despite major therapeutic progress. It is responsible for the majority of breast cancer–related deaths. Current treatments—hormone thera...
#Oncology #MetastaticBreastCancer #MBC #PlantMetabolites
Metastatic breast cancer (MBC) represents the most advanced stage of the disease and remains incurable despite major therapeutic progress. It is responsible for the majority of breast cancer–related deaths. Current treatments—hormone thera...
Read more
2025-10-15
Fasting hyperglycemia: a silent cancer risk factor?
Endocrinology and Metabolism Oncology
By Ana Espino | Published on october 15, 2025 | 2 min read
#EndocrinologyAndMetabolism #Oncology #PinkOctober #Hyperglycemia
Fasting hyperglycemia (FHG)—defined as elevated blood glucose levels outside of meals—is a common condition, particularly among individuals with type 2 diabetes or metabolic syndrome. Its role in the development of cardiovascular dise...
#EndocrinologyAndMetabolism #Oncology #PinkOctober #Hyperglycemia
Fasting hyperglycemia (FHG)—defined as elevated blood glucose levels outside of meals—is a common condition, particularly among individuals with type 2 diabetes or metabolic syndrome. Its role in the development of cardiovascular dise...
Read more
2025-10-14
Combined exercise: a winning strategy for cardiorespiratory fitness after breast cancer
Oncology
By Lila Rouland | Published October 14, 2025 | 3 min read
#Oncology #PhysicalExercise #BreastCancer #CardiorespiratoryFitness
Although breast cancer treatments have greatly improved survival, they also expose patients to an increased risk of cardiovascular toxicity. This toxicity can lead to a significant decline in cardiorespiratory fitn...
#Oncology #PhysicalExercise #BreastCancer #CardiorespiratoryFitness
Although breast cancer treatments have greatly improved survival, they also expose patients to an increased risk of cardiovascular toxicity. This toxicity can lead to a significant decline in cardiorespiratory fitn...
Read more
By Ana Espino | Published on october 13, 2025 | 3 min read
#PinkOctober #Cancer #PhysicalActivity #MedicalFollowUp
With the growing number of cancer survivors, care no longer ends with remission. Maintaining quality of life has become a key issue, notably through physical activity, which is recognized for its beneficial effects on fatigue, physica...
#PinkOctober #Cancer #PhysicalActivity #MedicalFollowUp
With the growing number of cancer survivors, care no longer ends with remission. Maintaining quality of life has become a key issue, notably through physical activity, which is recognized for its beneficial effects on fatigue, physica...
Read more
2025-10-12
Oncology
By Lila Rouland | Published October 12, 2025 | 3 min read
#PinkOctober #TripleNegativeBreastCancer #HER2Mutation #TrastuzumabDeruxtecanCapecitabine
The HER2 receptor (ERBB2) is a transmembrane protein with tyrosine kinase activity, involved in cell proliferation, tumor invasion, and angiogenesis. Its overexpression has historically been associated with a poo...
#PinkOctober #TripleNegativeBreastCancer #HER2Mutation #TrastuzumabDeruxtecanCapecitabine
The HER2 receptor (ERBB2) is a transmembrane protein with tyrosine kinase activity, involved in cell proliferation, tumor invasion, and angiogenesis. Its overexpression has historically been associated with a poo...
Read more
By Ana Espino | Published on october 11, 2025 | 3 min read
#BreastCancerAwareness #TargetedTherapy #Oncology
Breast cancer is the most common cancer among women worldwide. It is characterized by marked biological heterogeneity and often unpredictable evolution. Although advances in conventional treatments have improved overall survival, advanced and meta...
#BreastCancerAwareness #TargetedTherapy #Oncology
Breast cancer is the most common cancer among women worldwide. It is characterized by marked biological heterogeneity and often unpredictable evolution. Although advances in conventional treatments have improved overall survival, advanced and meta...
Read more
By Ana Espino | Published on october 10, 2025 | 3 min read
#ASC #BreastCancerAwareness
Adipose tissue–derived stromal cells (ASC) play a key role in many physiopathological processes, ranging from tissue repair to immune regulation and chronic inflammatory responses, as observed in metabolic diseases, fibrosis, and certain cancers. Long considered a homogeneo...
#ASC #BreastCancerAwareness
Adipose tissue–derived stromal cells (ASC) play a key role in many physiopathological processes, ranging from tissue repair to immune regulation and chronic inflammatory responses, as observed in metabolic diseases, fibrosis, and certain cancers. Long considered a homogeneo...
Read more
By Ana Espino | Published on october 9, 2025 | 3 min read
#AI #BreastCancer #BreastCancerAwareness
Breast cancer is a heterogeneous disease, and some aggressive forms require neoadjuvant therapy (NAT) before surgery. This treatment aims to reduce tumor size, improve surgical resection, and assess tumor sensitivity to the therapeutic agents used. However, the...
#AI #BreastCancer #BreastCancerAwareness
Breast cancer is a heterogeneous disease, and some aggressive forms require neoadjuvant therapy (NAT) before surgery. This treatment aims to reduce tumor size, improve surgical resection, and assess tumor sensitivity to the therapeutic agents used. However, the...
Read more
By Ana Espino | Published on october 8, 2025 | 3 min read
#BreastCancer #QuantumDots #QD #BreastCancerAwareness
Breast cancer remains the leading cause of cancer-related death among women worldwide. Despite progress in screening and treatment, many aggressive forms (triple-negative, HER2+) continue to evade conventional therapies. The main limitations lie in the l...
#BreastCancer #QuantumDots #QD #BreastCancerAwareness
Breast cancer remains the leading cause of cancer-related death among women worldwide. Despite progress in screening and treatment, many aggressive forms (triple-negative, HER2+) continue to evade conventional therapies. The main limitations lie in the l...
Read more
By Ana Espino | Published on october 7, 2025 | 3 min read
#Oncology #Eugenol #Phenol
Cancer is one of the leading causes of death worldwide, characterized by uncontrolled cell proliferation, metastasis, and resistance to treatment. Despite progress in targeted therapies and immunotherapy, current treatments often remain toxic, costly, and associated with a re...
#Oncology #Eugenol #Phenol
Cancer is one of the leading causes of death worldwide, characterized by uncontrolled cell proliferation, metastasis, and resistance to treatment. Despite progress in targeted therapies and immunotherapy, current treatments often remain toxic, costly, and associated with a re...
Read more
By Carolina Lima | Published October 6th, 2025 | 3 min read
#BreastCancerAwareness #PinkOctober #OncologyUpdates
Breast cancer is the most frequently diagnosed cancer among women worldwide and its prevention remains a global health priority. While genetic predisposition—particularly BRCA1 and BRCA2 mutations— often dominates public discourse, recent evidence suggests tha...
#BreastCancerAwareness #PinkOctober #OncologyUpdates
Breast cancer is the most frequently diagnosed cancer among women worldwide and its prevention remains a global health priority. While genetic predisposition—particularly BRCA1 and BRCA2 mutations— often dominates public discourse, recent evidence suggests tha...
Read more
By Lila Rouland | Published October 4th, 2025 | 2 min read
#Oncology #BreastCancer #Microbiome #Nutrition #Chemotherapy
Breast cancer (BC) remains the most common cancer among women worldwide and one of the leading causes of mortality. Its rising incidence is linked not only to genetic and hormonal factors, but also to modifiable lifestyle elements such as diet, obesit...
#Oncology #BreastCancer #Microbiome #Nutrition #Chemotherapy
Breast cancer (BC) remains the most common cancer among women worldwide and one of the leading causes of mortality. Its rising incidence is linked not only to genetic and hormonal factors, but also to modifiable lifestyle elements such as diet, obesit...
Read more
2025-10-03
Transforming lifestyle habits during chemotherapy: Insights from the LEANer trial
Oncology
By Lila Rouland | Published October 3rd, 2025 | 2 min read
#BreastCancer #Exercise #Chemotherapy
The Lifestyle, Exercise, and Nutrition Early After Diagnosis (LEANer) trial evaluated whether a structured lifestyle intervention could improve physical activity (PA) and dietary quality in women undergoing chemotherapy for breast cancer. While most studies focus on the post-...
#BreastCancer #Exercise #Chemotherapy
The Lifestyle, Exercise, and Nutrition Early After Diagnosis (LEANer) trial evaluated whether a structured lifestyle intervention could improve physical activity (PA) and dietary quality in women undergoing chemotherapy for breast cancer. While most studies focus on the post-...
Read more
By Ana Espino | Published on october 3rd, 2025 | 3 min read
#PinkOctober #BreastCancer #IBTR #Recurrence
Ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery for invasive breast cancer remains a major concern in clinical practice, both from oncological and psychological standpoints. Although therapeutic advances have helped reduce this risk, it s...
#PinkOctober #BreastCancer #IBTR #Recurrence
Ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery for invasive breast cancer remains a major concern in clinical practice, both from oncological and psychological standpoints. Although therapeutic advances have helped reduce this risk, it s...
Read more
By Ana Espino | Published on october 2nd, 2025 | 3 min read
#Oncology #PinkOctober #CDK4/6 #QualityOfLife
CDK4/6 inhibitors have revolutionized the treatment of advanced or metastatic HR+/HER2- breast cancer when combined with hormone therapy. These...
#Oncology #PinkOctober #CDK4/6 #QualityOfLife
CDK4/6 inhibitors have revolutionized the treatment of advanced or metastatic HR+/HER2- breast cancer when combined with hormone therapy. These...
Read more
